Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02046525Phase 2Completed
Phase 2, randomised trial in Dysbiosis (2 arms), sponsored by Washington University School of Medicine. Primary endpoint: Number of Participants With Restoration of Microbial Community Composition to the Pre-antibiotic State at 90 days. Started Mar 2014; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02046525.